Logo
    Search

    About this Episode

    Dr Otis Brawley speaks with Dr Qasim Hussaini, a Fellow in the Hematology and Medical Oncology Fellowship Program, about a study he recently presented on the impact of historical housing discrimination on present-day colon cancer outcomes.

    Recent Episodes from Johns Hopkins Kimmel Cancer Center Podcasts

    Cancer Matters with Dr Bill Nelson - Rogue Cells

    Cancer Matters with Dr Bill Nelson - Rogue Cells

    Dr Bill Nelson talks to Dr Rick Jones and Michael McCormick about their new book Rogue Cells: A Conversation on the Myths and Mysteries of Cancer. The book offers a blend of science and humor to help make the complexities of a cancer diagnosis more accessible to patients and their care partners. Learn more about the book here.

    Cancer Matters with Dr Bill Nelson - Technology Transfer and Corporate Partnerships

    Cancer Matters with Dr Bill Nelson - Technology Transfer and Corporate Partnerships

    Dr Bill Nelson speaks with Christy Wyskiel, the Executive Director of Johns Hopkins Technology Ventures, about the journey scientific discoveries take on their way to becoming life-saving treatments and the role JHTV plays in commercializing medical innovations.

    On Target with Dr Akila Viswanathan - The History of Brachytherapy

    On Target with Dr Akila Viswanathan - The History of Brachytherapy

    Dr Akila Viswanathan speaks with Dr Jesse Aronowitz, Emeritus Historian of the American Brachytherapy Society, about the history of the use of brachytherapy to treat cancer and the contributions of two early pioneers in the field from Johns Hopkins, Howard Kelly and Hugh Hampton Young.

    50th Anniversary of the Kimmel Cancer Center - Lung Cancer

    50th Anniversary of the Kimmel Cancer Center - Lung Cancer

    In this podcast looking back at the last 50 years of the Cancer Center at Johns Hopkins, Dr Bill Nelson and Dr Julie Brahmer examine the breakthroughs made by some of our leaders in lung cancer care and research and review the evolution of treatment over decades that is leading to longer and more durable survival in patients.